First Time Loading...

Eton Pharmaceuticals Inc
NASDAQ:ETON

Watchlist Manager
Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc
NASDAQ:ETON
Watchlist
Price: 3.76 USD 2.17%
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one ETON stock under the Base Case scenario is 4.16 USD. Compared to the current market price of 3.76 USD, Eton Pharmaceuticals Inc is Undervalued by 10%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ETON Relative Value
Base Case
4.16 USD
Undervaluation 10%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.1
P/S
P/S
Price to Sales
3.1
vs History
92
vs Industry
39
Median 3Y
4.1
Median 5Y
8.5
Industry
2.4
Forward
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
10
Median 3Y
-11.6
Median 5Y
-7.1
Industry
22.9
Forward
14.2
More Details
14.2
P/OCF
P/OCF
Price to OCF
14.2
vs History
17
vs Industry
29
Median 3Y
-12
Median 5Y
-8.2
Industry
17.1
More Details
25.8
P/FCFE
P/FCFE
Price to FCFE
25.8
vs History
14
vs Industry
19
Median 3Y
-6.8
Median 5Y
-7.9
Industry
23.2
More Details
6.2
P/B
P/B
Price to Book Value
6.2
vs History
71
vs Industry
10
Median 3Y
6.5
Median 5Y
7.4
Industry
2.1
More Details
2.4
EV/S
EV/S
Enterprise Value to Sales
2.4
vs History
95
vs Industry
46
Median 3Y
3.6
Median 5Y
7.2
Industry
2.6
Forward
1.8
More Details
3.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.6
vs History
57
vs Industry
55
Median 3Y
4.7
Median 5Y
4.2
Industry
5.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-12.3
Median 5Y
-7.8
Industry
13.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-10.4
Median 5Y
-7.6
Industry
17
Forward
26.2
More Details
11
EV/OCF
EV/OCF
Enterprise Value to OCF
11
vs History
19
vs Industry
35
Median 3Y
-10.7
Median 5Y
-8
Industry
15.8
More Details
12.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
12.5
vs History
14
vs Industry
27
Median 3Y
-6.5
Median 5Y
-6.5
Industry
17.6
More Details
8.8
EV/IC
EV/IC
Enterprise Value to IC
8.8
vs History
87
vs Industry
11
Median 3Y
11.4
Median 5Y
25.2
Industry
1.9
More Details

Multiples Across Competitors

ETON Competitors Multiples
Eton Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Eton Pharmaceuticals Inc
NASDAQ:ETON
96.6m USD 3.1 -103.2 -258.4 -63.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
724.1B USD 21.2 138.2 62.4 71.6
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.9 46.8 34.2 37.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
359.6B USD 4.4 8.9 11.8 15.6
US
Merck & Co Inc
NYSE:MRK
326.2B USD 5.3 141.5 33.6 53.4
UK
AstraZeneca PLC
LSE:AZN
188.4B GBP 5.1 39.5 140.7 225.8
CH
Novartis AG
SIX:NOVN
181.6B CHF 4.2 13.3 9.8 16.1
CH
Roche Holding AG
SIX:ROG
170.6B CHF 2.9 14.8 8.5 10.1
US
Pfizer Inc
NYSE:PFE
155.3B USD 2.7 73.3 10.9 16.2
P/E Multiple
Earnings Growth
US
Eton Pharmaceuticals Inc
NASDAQ:ETON
Average P/E: 59.5
Negative Multiple: -103.2 		N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
138.2
346%
DK
Novo Nordisk A/S
CSE:NOVO B
46.8
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
8.9
-20%
US
Merck & Co Inc
NYSE:MRK
141.5
7 454%
UK
AstraZeneca PLC
LSE:AZN
39.5
168%
CH
Novartis AG
SIX:NOVN
13.3
15%
CH
Roche Holding AG
SIX:ROG
14.8
26%
US
Pfizer Inc
NYSE:PFE
73.3
680%

See Also

Summary
ETON intrinsic value, competitors valuation, and company profile.
DCF Valuation
ETON stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ETON stock valuation using valuation multiples.
Wall Street Estimates
ETON price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ETON stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.